Eledon Pharmaceuticals (ELDN) EBIT (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted EBIT of -$21.2 million for Q1 2026, down 11.07% on a QoQ basis from -$19.1 million in Q3 2025, and down 17.91% year-over-year from -$25.8 million in Q1 2025.
Eledon Pharmaceuticals (ELDN) EBIT (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' EBIT history runs 14 years deep, the most recent figure standing at -$21.2 million for Q1 2026.
- Quarterly EBIT fell 17.91% year-over-year to -$21.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.9 million (down 6.79% YoY) and the FY2025 annual result came in at $17.4 million, up 124.69% from the prior year.
- EBIT was -$21.2 million for Q1 2026 at Eledon Pharmaceuticals, down from -$19.1 million in the prior quarter.
- Across five years, EBIT topped out at -$9.3 million in Q2 2022 and bottomed at -$58.7 million in Q4 2022.
- A 5-year average of -$17.8 million and a median of -$12.8 million in 2023 frame the typical range for EBIT.
- Annual changes were most pronounced in 2022 — EBIT tumbled 525.34% — and 2023, when it jumped 82.38%.
- Eledon Pharmaceuticals' EBIT stood at -$58.7 million in 2022, then jumped by 82.38% to -$10.3 million in 2023, then tumbled by 138.89% to -$24.7 million in 2024, then rose by 22.78% to -$19.1 million in 2025, then dropped by 11.07% to -$21.2 million in 2026.
- Business Quant data shows ELDN's EBIT at -$21.2 million in Q1 2026, -$19.1 million in Q3 2025, and -$24.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Eledon Pharmaceuticals | 5.43 Mn | -105.66 Mn | - | -21.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.18 Mn |
| Sep 30, 2025 | -19.07 Mn |
| Jun 30, 2025 | -24.73 Mn |
| Mar 31, 2025 | -17.96 Mn |
| Dec 31, 2024 | -24.70 Mn |
| Sep 30, 2024 | -20.51 Mn |
| Jun 30, 2024 | -14.50 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Dec 31, 2023 | -10.34 Mn |
| Sep 30, 2023 | -11.20 Mn |
| Jun 30, 2023 | -10.35 Mn |
| Mar 31, 2023 | -11.11 Mn |
| Dec 31, 2022 | -58.69 Mn |
| Sep 30, 2022 | -10.60 Mn |
| Jun 30, 2022 | -9.28 Mn |
| Mar 31, 2022 | -9.86 Mn |
| Dec 31, 2021 | -9.39 Mn |
| Sep 30, 2021 | -10.51 Mn |
| Jun 30, 2021 | -7.97 Mn |
| Mar 31, 2021 | -9.01 Mn |